HIV

People living with HIV reported feeling inferiority due to HIV and gloomy feelings during the COVID-19 pandemic, as researchers linked internalized HIV stigma to depressive symptoms.

Separate machine learning models were able to effectively predict both the length of hospital stay and the risk of prolonged hospitalization in people living with HIV.

Patients living with HIV had a lower uptake of hepatitis A virus vaccination despite it being recommended for this population.

The deterioration of bones could contribute to the loss of teeth in women who are postmenopausal and living with HIV.

The researchers noted the need for strategies to better support women living with HIV with breast cancer during toxic therapies to improve outcomes among this growing population.

The top-read topics in HIV for 2023 included dried blood tests for HIV, people with HIV facing stigmas, and vitamin D supplementation in women with HIV.

The top 5 most-read news content for 2023 featured COVID-19 vaccination uptake and its relation to HIV viral suppression, those more likely to get vitamin D supplements, and recurrence of Clostridioides difficile infection.

From 2013 to 2022, the all-cause mortality rate among patients with HIV in China declined from 5.4% to 2.7%.

Infants with HIV could be spared from requiring lifetime antiretroviral (ART) if treated within hours of birth to disrupt formation of HIV viral reservoirs.

Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.

The researchers suggested prioritizing and optimizing HIV and general health services for children younger than age 5 living with HIV and receiving ART to help address their disproportionately poorer outcomes.

Research on HIV and aging should be the focus of future research as World AIDS Day brings the chronic illness to the forefront.

The Targeted Minimum Loss-based Estimation proved the most accurate capture-recapture model in estimating hidden populations of patients with HIV.

Patients who have HIV and are using antiretroviral therapy (ART) did not have adverse outcomes when using nivolumab for cancer treatment.

IQ score could be detrimentally influenced by an individual’s HIV infection, both through neurons and the gut.

Compared with infants born at term, infants born preterm following exposure to HIV had no observed increase in acquisition of HIV.

Residents grew more knowledgeable and more comfortable with using pre-exposure prophylaxis (PrEP) drugs for prevention against HIV after training was included in their residency program.

Medicare may cover full cost of preexposure prophylaxis drugs; rules aim to prevent excessive compensation in Medicare Advantage (MA) market; health officials advocate for widespread syphilis testing and intervention.

Mothers in the United States were surveyed about the time of disclosure of their HIV status to their children, with internalized stigma of HIV a significantly associated factor.

Men who had sex with men had increased HIV testing after participating in an intervention.

Patients with HIV who started highly active antiretroviral therapy (ART) for 6 months had an improved immunohematological profile by the end of the study.

Patients living with HIV had an interest in future use of telehealth due to high satisfaction in the care provided.

Individuals aged up to 24 years living with HIV were likely to be satisfied with and would recommend telehealth services to their friends, a recent study found.

People who inject drugs tended to have quicker COVID-19 vaccination uptake if they had HIV infection and viral suppression.

Patient comorbidities should be considered when prescribing antiretroviral therapy (ART) to treat HIV to avoid comedication drug toxicities.

Americans with college degrees live longer than those without; pre-exposure prophylaxis (PrEP) accessibility is low for Black women; new COVID-19 vaccine access is proving difficult for some Americans, as the COVID-19 vaccine card is being phased out.

Prevalence of hepatitis B virus (HBV) decreased in people living with HIV in Germany when vaccination coverage increased due to general recommendations and catch-up vaccination efforts.

Among Latino men who have sex with men (MSM), access to and use of pre-exposure prophylaxis (PrEP) remain at suboptimal levels, despite this population of individuals having disproportionately high rates of diagnosed HIV in the United States.

ViiV Healthcare is developing a self-injectable HIV drug similar to Cabenuva; HHS met with insurance companies to resolve COVID-19 vaccine coverage issues; the FDA has greenlit drugmaker Novo Nordisk to add reports of ileus, or intestinal blockage, to its Ozempic label.

Patients with limited English proficiency need their mobile health (mHealth) interventions tailored more closely to their needs to improve equity of access for patients with HIV.